Anteris Technologies Global (NASDAQ:AVR) Shares Down 5.8% – Should You Sell?

by · The Cerbat Gem

Anteris Technologies Global Corp. (NASDAQ:AVR – Get Free Report)’s stock price traded down 5.8% on Tuesday . The company traded as low as $8.79 and last traded at $9.06. 231,645 shares traded hands during trading, a decline of 79% from the average session volume of 1,125,993 shares. The stock had previously closed at $9.62.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on AVR shares. Cantor Fitzgerald restated an “overweight” rating and set a $15.00 price target on shares of Anteris Technologies Global in a research note on Friday, March 27th. Barclays boosted their target price on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Wells Fargo & Company assumed coverage on Anteris Technologies Global in a research report on Wednesday, March 11th. They set an “overweight” rating and a $16.00 target price on the stock. Finally, Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Four equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $16.00.

Check Out Our Latest Stock Report on Anteris Technologies Global

Anteris Technologies Global Stock Performance

The business has a 50 day simple moving average of $6.23 and a two-hundred day simple moving average of $5.54. The firm has a market capitalization of $905.26 million, a P/E ratio of -4.17 and a beta of 1.32.

Anteris Technologies Global (NASDAQ:AVR – Get Free Report) last issued its quarterly earnings data on Tuesday, May 12th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.01). The business had revenue of $0.49 million for the quarter, compared to analysts’ expectations of $0.77 million. Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.During the same period in the previous year, the firm posted ($0.61) EPS. On average, equities analysts anticipate that Anteris Technologies Global Corp. will post -1.14 earnings per share for the current fiscal year.

Institutional Trading of Anteris Technologies Global

Several institutional investors and hedge funds have recently made changes to their positions in the stock. JPMorgan Chase & Co. raised its position in Anteris Technologies Global by 32.7% during the third quarter. JPMorgan Chase & Co. now owns 1,417,627 shares of the company’s stock valued at $6,379,000 after purchasing an additional 349,299 shares in the last quarter. The Manufacturers Life Insurance Company purchased a new position in shares of Anteris Technologies Global in the 1st quarter worth about $111,000. Bank of New York Mellon Corp increased its position in shares of Anteris Technologies Global by 126.3% during the 1st quarter. Bank of New York Mellon Corp now owns 170,653 shares of the company’s stock valued at $947,000 after purchasing an additional 95,259 shares during the last quarter. SummitTX Capital L.P. bought a new stake in shares of Anteris Technologies Global in the 1st quarter worth approximately $1,326,000. Finally, Anson Funds Management LP bought a new stake in shares of Anteris Technologies Global in the 1st quarter worth approximately $1,126,000.

About Anteris Technologies Global

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Featured Stories